PhoenixBio Co., Ltd. (TYO:6190)
245.00
-4.00 (-1.61%)
Nov 18, 2026, 12:38 PM JST
PhoenixBio Market Cap
PhoenixBio has a market cap or net worth of 997.2 million as of November 17, 2026. It is the 43,739th most valuable company in the world and the 3,869th biggest in Japan. Its market cap has decreased by 44.70% in one year.
Market Cap
997.20M
Enterprise Value
315.20M
Revenue
1.37B
Global Rank
Country Rank
#3,869 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since March 18, 2016, PhoenixBio's market cap has decreased from 8.06B to 997.20M, a decrease of -87.62%. That is a compound annual growth rate of -17.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 997.20M | -49.38% |
| Dec 30, 2025 | 1.97B | 47.38% |
| Dec 30, 2024 | 1.34B | -23.59% |
| Dec 29, 2023 | 1.75B | -25.42% |
| Dec 30, 2022 | 2.35B | 39.61% |
| Dec 30, 2021 | 1.68B | -13.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chordia Therapeutics | 3.33B |
| Modalis Therapeutics | 3.18B |
| Ribomic | 3.18B |
| Kohjin Bio | 3.14B |
| PRISM BioLab Co.,LTD | 3.10B |
| Transgenic Group | 3.03B |
| Human Metabolome Technologies | 3.03B |
| D. Western Therapeutics Institute | 2.76B |